Martina E. Daly

1.9k citations
38 papers · 1.4k · h-index 21

Impact in

  • Hematology top 1%
    • Platelet Disorders and Treatments
    • Blood Coagulation and Thrombosis Mechanisms
    • Blood groups and transfusion
    • Hemophilia Treatment and Research
  • Internal Medicine top 2%
    • Venous Thromboembolism Diagnosis and Management

Papers in

  • Hematology 31
    • Platelet Disorders and Treatments 23
    • Blood groups and transfusion 8
    • Blood Coagulation and Thrombosis Mechanisms 7
    • Hemophilia Treatment and Research 3
  • Molecular Biology 9
    • Receptor Mechanisms and Signaling 3
Co-authors
I. R. Peake (9 shared papers)Anne Goodeve (7 shared papers)Steve P. Watson (8 shared papers)K. K. Hampton (2 shared papers)Andrew Mumford (6 shared papers)F. E. Preston (2 shared papers)Nicholas Beauchamp (2 shared papers)Peter Cooper (2 shared papers)
Journals
Blood (11 papers)British Journal of Haematology (4 papers)PLoS ONE (2 papers)Nucleic Acids Research (2 papers)Platelets (2 papers)
Partner nations
United KingdomIrelandTürkiye

In The Last Decade

Martina E. Daly

38 papers receiving 1.4k citations

Peers

Martina E. Daly
Comparison fields: 5 of 99
  • Hematology 950
  • Internal Medicine 157
  • Genetics 219
  • Cardiology and Cardiovascular Medicine 232
  • Immunology and Allergy 50
Replace Shiro Koizume with:
Shiro Koizume Japan
Steven Pirie‐Shepherd United States
H. Jean Khoury United States
Linnea Chap United States
Maria Diamandis Canada
Reet Koomägi Germany
Massimo Gentile Italy
Thorsten Klampfl Austria
Deborah Doss United States
Sharianne G. Louie United States
Martina E. Daly relative to Shiro Koizume Japan Shiro Koizume's profile →
Citations per field
00.5×5×11.6×
Shiro Koizume · 1×
Citations per year

Countries citing papers authored by Martina E. Daly

Since Specialization
Citations

This map shows the geographic impact of Martina E. Daly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martina E. Daly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martina E. Daly more than expected).

Fields of papers citing papers by Martina E. Daly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martina E. Daly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martina E. Daly. The network helps show where Martina E. Daly may publish in the future.

Co-authors

The 25 scholars most cited alongside Martina E. Daly, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Martina E. Daly Line = papers co-authored together Martina E. Daly links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.

#Work
1
High prevalence of a mutation in the factor V gene within the U.K. population: relationship to activated protein C resistance and familial thrombosis
British Journal of Haematology ·Nicholas Beauchamp, Martina E. Daly, K. K. Hampton, Peter Cooper, F. E. Preston, I. R. Peake
1994121
2
Genetic analysis, phenotypic diagnosis, and risk of venous thrombosis in families with inherited deficiencies of protein S
Blood ·Michael Makris, M.J. Leach, Nick Beauchamp, Martina E. Daly, Peter Cooper, K. K. Hampton, Pauline Bayliss, I. R. Peake, George J. Miller, F. E. Preston
200092
3
Evaluation of participants with suspected heritable platelet function disorders including recommendation and validation of a streamlined agonist panel
Blood ·Ban B. Dawood, Gillian Lowe, Marie Lordkipanidzé, Danai Bem, Martina E. Daly, (unknown), Andrew Mumford, Jonathan T. Wilde, Steve P. Watson
201281
4
Enrichment of FLI1 and RUNX1 mutations in families with excessive bleeding and platelet dense granule secretion defects
Blood ·Jacqueline Stockley, Neil V. Morgan, Danai Bem, Gillian Lowe, Marie Lordkipanidzé, Ban B. Dawood, Michael A. Simpson, Kirsty Macfarlane, Kevin Horner, Vincenzo Leo, Katherine Talks, Jayashree Motwani, Jonathan T. Wilde, Peter W. Collins, Michael Makris, Steve P. Watson, Martina E. Daly
201379
5
Hemostatic Regulators of Tumor Angiogenesis: A Source of Antiangiogenic Agents for Cancer Treatment?
JNCI Journal of the National Cancer Institute ·Martina E. Daly
200374
6
Analysis of intracellular storage and regulated secretion of 3 von Willebrand disease–causing variants of von Willebrand factor
Blood ·Grégoire Michaux, Lindsay Hewlett, Sarah L. Messenger, Anne Goodeve, I. R. Peake, Martina E. Daly, Daniel F. Cutler
200372
7
SLFN14 mutations underlie thrombocytopenia with excessive bleeding and platelet secretion defects
Journal of Clinical Investigation ·Sarah J. Fletcher, Ben Johnson, Gillian Lowe, Danai Bem, Sian Drake, Marie Lordkipanidzé, Isabel Sánchez Guiú, Ban B. Dawood, José Rivera, Michael A. Simpson, Martina E. Daly, Jayashree Motwani, Peter W. Collins, Steve P. Watson, Neil V. Morgan, (unknown)
201564
8
Common sequence variations in the P2Y12 and CYP3A5 genes do not explain the variability in the inhibitory effects of clopidogrel therapy
Platelets ·Simon Smith, Heather M. Judge, Gary Peters, Martin Armstrong, Pierre Fontana, Pascale Gaussem, Martina E. Daly, Robert F. Storey
200661
9
Identification and characterization of a novel P2Y12 variant in a patient diagnosed with type 1 von Willebrand disease in the European MCMDM-1VWD study
Blood ·Martina E. Daly, Ban B. Dawood, Will Lester, I. R. Peake, Francesco Rodeghiero, Anne Goodeve, Michael Makris, Jonathan T. Wilde, Andrew Mumford, (unknown), Stuart J. Mundell
200960
10
Characterization of multiple platelet activation pathways in patients with bleeding as a high-throughput screening option: use of 96-well Optimul assay
Blood ·Marie Lordkipanidzé, Gillian Lowe, Nicholas S. Kirkby, Melissa V. Chan, Martina H. Lundberg, Neil V. Morgan, Danai Bem, Shaista P. Nisar, Vincenzo Leo, Matthew L. Jones, Stuart J. Mundell, Martina E. Daly, Andrew Mumford, Timothy D. Warner, Steve P. Watson
201457
11
Antithrombin Cambridge, 384 Ala to Pro: A new variant identified using the polymerase chain reaction
FEBS Letters ·David J. Perry, Paul Harper, Stuart Fairham, Martina E. Daly, R.W. Carrell
198953
12
A novel von Willebrand disease–causing mutation (Arg273Trp) in the von Willebrand factor propeptide that results in defective multimerization and secretion
Blood ·Simon Allen, Adel Abuzenadah, Joanna Hinks, Joanna L. Blagg, Türkiz Gursel, Jørgen Ingerslev, Anne Goodeve, I. R. Peake, Martina E. Daly
200052
13
Two novel type 2N von Willebrand disease–causing mutations that result in defective factor VIII binding, multimerization, and secretion of von Willebrand factor
Blood ·Simon Allen, Adel Abuzenadah, Joanna L. Blagg, Joanna Hinks, I. M. Nesbitt, Anne Goodeve, Türkiz Gursel, Jørgen Ingerslev, I. R. Peake, Martina E. Daly
200050
14
A novel thromboxane A2 receptor D304N variant that abrogates ligand binding in a patient with a bleeding diathesis
Blood ·Andrew Mumford, Ban B. Dawood, Martina E. Daly, Sherina L. Murden, Michael D. Williams, Majd Protty, Jennifer C. Spalton, Mark Wheatley, Stuart J. Mundell, Steve P. Watson
200948
15
The prevalence of, and molecular defects underlying, inherited protein S deficiency in the general population
British Journal of Haematology ·Nicholas Beauchamp, Anne C. Dykes, Nirzari Parikh, Robert C. Tait, Martina E. Daly
200442
16
An intact PDZ motif is essential for correct P2Y12 purinoceptor traffic in human platelets
Blood ·Shaista P. Nisar, Martina E. Daly, Augusto B. Federici, Andrea Artoni, Andrew Mumford, (unknown), Stuart J. Mundell
201136
17
Antithrombin Dublin (−3 Val → Glu): an N‐terminal variant which has an aberrant signal peptidase cleavage site
FEBS Letters ·Martina E. Daly, David A. Bruce, David J. Perry, John C. Price, Paul Harper, Anne O’Meara, Robin W. Carrell
199033
18
Synthesis of polyfluorodibenz[b,f][1,4]oxazepines by the cyclization of 2-[(polyfluorobenzylidene)amino]phenols
Journal of Fluorine Chemistry ·Cara L. Allaway, Martina E. Daly, M. Nieuwenhuyzen, Graham C. Saunders
200229
19
Assembly of Multimeric von Willebrand Factor Directs Sorting of P-Selectin
Arteriosclerosis Thrombosis and Vascular Biology ·Caroline Hop, Andrea M. Guilliatt, Martina E. Daly, Hubert P. de Leeuw, Herm‐Jan M. Brinkman, I. R. Peake, Jan A. van Mourik, Hans Pannekoek
200028
20
Endoplasmic Reticulum Retention and Prolonged Association of a von Willebrand's Disease-Causing von Willebrand Factor Variant with ERp57 and Calnexin
Biochemical and Biophysical Research Communications ·Simon Allen, Anne Goodeve, I. R. Peake, Martina E. Daly
200128

About Martina E. Daly

Martina E. Daly is a scholar working on Hematology, Molecular Biology, Genetics, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism, having authored 38 papers that have together received 1.4k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (23 papers), Blood groups and transfusion (8 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers), Antiplatelet Therapy and Cardiovascular Diseases (5 papers), Diabetes Treatment and Management (4 papers), Hemophilia Treatment and Research (3 papers), Venous Thromboembolism Diagnosis and Management (3 papers) and Receptor Mechanisms and Signaling (3 papers). The work is most often cited by research in Hematology (950 citations), Internal Medicine (157 citations), Genetics (219 citations), Cardiology and Cardiovascular Medicine (232 citations) and Immunology and Allergy (50 citations). Martina E. Daly has collaborated with scholars based in United Kingdom, Ireland and Türkiye. Frequent co-authors include I. R. Peake, Anne Goodeve, Steve P. Watson, K. K. Hampton, Andrew Mumford, F. E. Preston, Nicholas Beauchamp, Peter Cooper, Ban B. Dawood and Gillian Lowe. Their work appears in journals such as Blood, British Journal of Haematology, PLoS ONE, Nucleic Acids Research and Platelets.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shiro KoizumeBreakdown of academic impact, for papers by Steven Pirie‐ShepherdBreakdown of academic impact, for papers by H. Jean KhouryBreakdown of academic impact, for papers by Linnea ChapBreakdown of academic impact, for papers by Maria DiamandisBreakdown of academic impact, for papers by Reet KoomägiBreakdown of academic impact, for papers by Massimo GentileBreakdown of academic impact, for papers by Thorsten KlampflBreakdown of academic impact, for papers by Deborah DossBreakdown of academic impact, for papers by Sharianne G. Louie